Sharing Life Sciences Innovations
Strong communication in biotech is lacking
Many biotech management teams fail to reach out to investors in a clear and appealing way.
Belgium showcases expertise on Immunotherapy at the world’s largest Biotechnology Conference
Belgium again attends the BIO International Convention 2017 with a stunning 74 companies and organizations and 135 delegates on one of the most vibrant pavilions at the conference. The Belgian del…
ABLYNX APPOINTS MARKUS EWERT AS CHIEF BUSINESS OFFICER
Ablynx today announced the appointment of Markus L.E. Ewert, PhD, MBA, as Chief Business Officer (CBO). Effective from 20 June 2017, Dr Ewert will lead the Company's business development and corpo…
Biocartis launches CE-marked IVD test for lung cancer
Biocartis, an innovative molecular diagnostics company, today announced the CE-marking of the Idylla™ EGFR Mutation Test, as such achieving an important milestone in Biocartis' lung cancer menu. T…
IDO 1: a promising new target for immunotherapy
iTeos Therapeutics started in 2012 as a spin-off from the Ludwig Institute for Cancer Research (LICR), one of the top three cancer institutes in the world, and the UCL. In 2014, they licensed righ…
Immunotherapy: a paradigm shift in cancer treatment
An excerpt from the BioVox White paper on Cancer Immunotherapy.
Lars Klareskog pushes rheumatology beyond symptomatic treatment
Over the years, the perception of inflammatory diseases has changed drastically. The advent of cytokine inhibitors meant great improvement to many patients, especially those suffering from rheumat…
Reinforcing veins with computer simulations
Each year, more than two million patients worldwide undergo a procedure called coronary artery bypass grafting (CABG). CABG is used to treat blocked arteries and restore normal blood flow to the h…
Diagnosing rare genetic conditions within minutes
Moon is a new software package that, within minutes, diagnoses patients who suffer from rare diseases. All the software requires are the patient’s symptoms and sequencing data. Moon then applies a…
Sylvie Janssen in Manhattan - Belgian scientist living abroad
Sylvie Janssens lives in Manhattan, New York, where she relocated after earning her PhD in biotechnology at Ghent University. She studied biomedical sciences at Ghent University, and prior to that…
Curing all diseases in the next 20 years: the new hype amongst billionaires?
Despite the initial intent of charitable foundations to be not-for-profit, some of them tend to morph into organizations with bigger aspirations.
Investing in European biotech faced with many challenges
Investing in biotech companies is a capital-intensive and risky business, and it’s no secret that more money and less risk-averse investors are available in the US than in Europe. To keep innovati…
Join our 20.000 subscribers and receive the newsletter for free!
Upcoming events
Liquid biopsies & cancer
University Hall, Naamsestraat 22, Leuven
Mon 28 Aug 2017 - Wed 30 Aug 2017
28 Aug 08:30
- 30 Aug 17:00
The Leuven Cancer Institute (LKI) is happy to announce its upcoming symposium on "Liquid Biopsies & Cancer", on August 28-30, 2017 in Leuven (University Hall). The symposium is organised by th…
Principles of Biosafety
UAntwerpen Stadscampus: Prinsstraat 13
2000 Antwerpen, Campus Mutsaard: Mutsaardstraat 31
2000 Antwerpen (11 & 14 Sept)
ITM: Nationalestraat 155, 2000 Antwerpen (12, 13 &15 Sept)
Mon 11 Sep 2017 - Fri 15 Sep 2017
11 Sep 08:30
- 15 Sep 17:00
A comprehensive course with lectures and practical demonstrations on biosafety and biorisk management.
Next-Generation Antibodies and Protein Analysis (2nd Edition)
Ghent, Belgium
Mon 16 Oct 2017 - Tue 17 Oct 2017
16 Oct 08:30
- 17 Oct 17:30
The Next-Generation Antibodies and Protein Analysis conference is set to make another world class meeting, bringing together an exciting selection of top speakers and newly emerged companies.
